182 related articles for article (PubMed ID: 33708866)
1. Survival analysis of second primary malignancies after cervical cancer using a competing risk model: implications for prevention and surveillance.
Li R; Zhang Y; Ma B; Tan K; Lynn HS; Wu Z
Ann Transl Med; 2021 Feb; 9(3):239. PubMed ID: 33708866
[TBL] [Abstract][Full Text] [Related]
2. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
3. Second Primary Malignancies in Patients With Hepatocellular Carcinoma: A Population-Based Analysis.
Kong J; Yu G; Si W; Li G; Chai J; Liu Y; Liu J
Front Oncol; 2021; 11():713637. PubMed ID: 34497765
[TBL] [Abstract][Full Text] [Related]
4. Risk Prediction of Second Primary Malignancies in Primary Early-Stage Ovarian Cancer Survivors: A SEER-Based National Population-Based Cohort Study.
Xu J; Huang C; Wu Z; Xu H; Li J; Chen Y; Wang C; Zhu J; Qin G; Zheng X; Yu Y
Front Oncol; 2022; 12():875489. PubMed ID: 35664751
[TBL] [Abstract][Full Text] [Related]
5. Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy.
Zhang B; Guo K; Zheng X; Sun L; Shen M; Ruan S
Front Oncol; 2020; 10():1154. PubMed ID: 32766153
[No Abstract] [Full Text] [Related]
6. Risk prediction of second primary malignancies in primary colorectal neuroendocrine neoplasms patients: a population-based study.
Ding X; Yang X; Hao Q; Xu F; Yu X; Rao L; Yuan C; Tian S
J Endocrinol Invest; 2023 Sep; 46(9):1881-1889. PubMed ID: 36870016
[TBL] [Abstract][Full Text] [Related]
7. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
[TBL] [Abstract][Full Text] [Related]
8. Mortality patterns of patients with tonsillar squamous cell carcinoma: a population-based study.
Wang J; Li X; Niu D; Huang J; Ye E; Zhao Y; Yue S; Hou X; Wu J
Front Endocrinol (Lausanne); 2023; 14():1158593. PubMed ID: 38130394
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
Yang J; Wu F; An H; Gan H
Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
[TBL] [Abstract][Full Text] [Related]
10. Risk prediction of second primary malignancies after gynecological malignant neoplasms resection with and without radiation therapy: a population-based surveillance, epidemiology, and end results (SEER) analysis.
Wang J; Zhang C; Xiang Y; Han B; Cheng Y; Tong Y; Yan D
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12703-12711. PubMed ID: 37452852
[TBL] [Abstract][Full Text] [Related]
11. A Novel Overall Survival Nomogram Prediction of Secondary Primary Malignancies after Hypopharyngeal Cancer: A Population-Based Study.
Wan M; Zhao D; Sun Y; Wang W
J Oncol; 2022; 2022():4681794. PubMed ID: 35528241
[TBL] [Abstract][Full Text] [Related]
12. Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study.
Zhou B; Zang R; Song P; Zhang M; Bie F; Bai G; Li Y; Huai Q; Han Y; Gao S
J Transl Med; 2023 Jan; 21(1):10. PubMed ID: 36624443
[TBL] [Abstract][Full Text] [Related]
13. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
14. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
[TBL] [Abstract][Full Text] [Related]
15. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis.
Wang T; Zhang J; Wang W; Yang X; Kong J; Shen S; Wang W
Cancer Manag Res; 2020; 12():11015-11029. PubMed ID: 33173335
[TBL] [Abstract][Full Text] [Related]
17. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F
Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785
[TBL] [Abstract][Full Text] [Related]
18. Incidence features of second primary malignancy among gastric cancer survivors, 1992-2012.
Li S; Luo Y; Hou Q; Chu H; Zheng H
Transl Cancer Res; 2020 Nov; 9(11):7001-7011. PubMed ID: 35117306
[TBL] [Abstract][Full Text] [Related]
19. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
20. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]